FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2785220350> ?p ?o ?g. }

• W2785220350 endingPage "446" @default.
• W2785220350 startingPage "446" @default.
• W2785220350 abstract "Current intra-arterial chemotherapy (IAC) drug regimens for retinoblastoma have ocular and vascular toxicities. No small-animal model of IAC exists to test drug efficacy and toxicity in vivo for IAC drug discovery. The purpose of this study was to develop a small-animal model of IAC and to analyze the ocular tissue penetration, distribution, pharmacokinetics, and treatment efficacy.Following selective ophthalmic artery (OA) catheterization, melphalan (0.4 to 1.2 mg/kg) was injected. For pharmacokinetic studies, rabbits were euthanized at 0.5, 1, 2, 4, or 6 hours following intra-OA infusion. Drug levels were determined in vitreous, retina, and blood by liquid chromatography tandem mass spectrometry. To assess toxicity, angiograms, photography, fluorescein angiography, and histopathology were performed. For in situ tissue drug distribution, matrix-assisted laser desorption/ionization imaging mass spectrometry (MALDI-IMS) was performed. The tumor model was created by combined subretinal/intravitreal injection of human WERI-Rb1 retinoblastoma cells; the tumor was treated in vivo with intra-arterial melphalan or saline; and induction of tumor death was measured by cleaved caspase-3 activity.OA was selectively catheterized for 79 of 79 (100%) eyes in 47 of 47 (100%) rabbits, and melphalan was delivered successfully in 31 of 31 (100%) eyes, without evidence of vascular occlusion or retinal damage. For treated eyes, maximum concentration (Cmax) in the retina was 4.95 μM and area under the curve (AUC0→∞) was 5.26 μM·h. Treated eye vitreous Cmax was 2.24 μM and AUC0→∞ was 4.19 μM·h. Vitreous Cmax for the treated eye was >100-fold higher than for the untreated eye (P = 0.01), and AUC0→∞ was ∼50-fold higher (P = 0.01). Histology-directed MALDI-IMS revealed highest drug localization within the retina. Peripheral blood Cmax was 1.04 μM and AUC0→∞ was 2.07 μM·h. Combined subretinal/intravitreal injection of human retinoblastoma cells led to intra-retinal tumors and subretinal/vitreous seeds, which could be effectively killed in vivo with intra-arterial melphalan.This first small-animal model of IAC has excellent vitreous and retinal tissue drug penetration, achieving levels sufficient to kill human retinoblastoma cells, facilitating future IAC drug discovery." @default.
• W2785220350 created "2018-02-02" @default.
• W2785220350 creator A5004341044 @default.
• W2785220350 creator A5010067150 @default.
• W2785220350 creator A5010542605 @default.
• W2785220350 creator A5015428739 @default.
• W2785220350 creator A5018081716 @default.
• W2785220350 creator A5029125087 @default.
• W2785220350 creator A5034404550 @default.
• W2785220350 creator A5048511552 @default.
• W2785220350 creator A5060483072 @default.
• W2785220350 creator A5060993338 @default.
• W2785220350 creator A5061432494 @default.
• W2785220350 creator A5078197329 @default.
• W2785220350 creator A5082087932 @default.
• W2785220350 date "2018-01-24" @default.
• W2785220350 modified "2023-10-16" @default.
• W2785220350 title "Pharmacokinetics, Tissue Localization, Toxicity, and Treatment Efficacy in the First Small Animal (Rabbit) Model of Intra-Arterial Chemotherapy for Retinoblastoma" @default.
• W2785220350 cites W10347719 @default.
• W2785220350 cites W128527036 @default.
• W2785220350 cites W1857598851 @default.
• W2785220350 cites W1966101765 @default.
• W2785220350 cites W1973662347 @default.
• W2785220350 cites W2009934230 @default.
• W2785220350 cites W2019807638 @default.
• W2785220350 cites W2027148718 @default.
• W2785220350 cites W2031233356 @default.
• W2785220350 cites W2033523274 @default.
• W2785220350 cites W2045388751 @default.
• W2785220350 cites W2050441456 @default.
• W2785220350 cites W2056435264 @default.
• W2785220350 cites W2061637512 @default.
• W2785220350 cites W2067611128 @default.
• W2785220350 cites W2069339449 @default.
• W2785220350 cites W2078839964 @default.
• W2785220350 cites W2082576757 @default.
• W2785220350 cites W2097250646 @default.
• W2785220350 cites W2105363094 @default.
• W2785220350 cites W2120033395 @default.
• W2785220350 cites W2120363483 @default.
• W2785220350 cites W2124519417 @default.
• W2785220350 cites W2134548605 @default.
• W2785220350 cites W2140359717 @default.
• W2785220350 cites W2142665413 @default.
• W2785220350 cites W2157949719 @default.
• W2785220350 cites W2162101139 @default.
• W2785220350 cites W2162201423 @default.
• W2785220350 cites W2164687852 @default.
• W2785220350 cites W2166720993 @default.
• W2785220350 cites W2168914937 @default.
• W2785220350 cites W2213545278 @default.
• W2785220350 cites W2236957533 @default.
• W2785220350 cites W2315192299 @default.
• W2785220350 cites W2325770571 @default.
• W2785220350 cites W2343865241 @default.
• W2785220350 doi "https://doi.org/10.1167/iovs.17-22302" @default.
• W2785220350 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5783625" @default.
• W2785220350 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29368001" @default.
• W2785220350 hasPublicationYear "2018" @default.
• W2785220350 type Work @default.
• W2785220350 sameAs 2785220350 @default.
• W2785220350 citedByCount "33" @default.
• W2785220350 countsByYear W27852203502018 @default.
• W2785220350 countsByYear W27852203502019 @default.
• W2785220350 countsByYear W27852203502020 @default.
• W2785220350 countsByYear W27852203502021 @default.
• W2785220350 countsByYear W27852203502022 @default.
• W2785220350 countsByYear W27852203502023 @default.
• W2785220350 crossrefType "journal-article" @default.
• W2785220350 hasAuthorship W2785220350A5004341044 @default.
• W2785220350 hasAuthorship W2785220350A5010067150 @default.
• W2785220350 hasAuthorship W2785220350A5010542605 @default.
• W2785220350 hasAuthorship W2785220350A5015428739 @default.
• W2785220350 hasAuthorship W2785220350A5018081716 @default.
• W2785220350 hasAuthorship W2785220350A5029125087 @default.
• W2785220350 hasAuthorship W2785220350A5034404550 @default.
• W2785220350 hasAuthorship W2785220350A5048511552 @default.
• W2785220350 hasAuthorship W2785220350A5060483072 @default.
• W2785220350 hasAuthorship W2785220350A5060993338 @default.
• W2785220350 hasAuthorship W2785220350A5061432494 @default.
• W2785220350 hasAuthorship W2785220350A5078197329 @default.
• W2785220350 hasAuthorship W2785220350A5082087932 @default.
• W2785220350 hasBestOaLocation W27852203501 @default.
• W2785220350 hasConcept C104317684 @default.
• W2785220350 hasConcept C112705442 @default.
• W2785220350 hasConcept C118487528 @default.
• W2785220350 hasConcept C126322002 @default.
• W2785220350 hasConcept C141071460 @default.
• W2785220350 hasConcept C142724271 @default.
• W2785220350 hasConcept C150903083 @default.
• W2785220350 hasConcept C185592680 @default.
• W2785220350 hasConcept C207001950 @default.
• W2785220350 hasConcept C22979827 @default.
• W2785220350 hasConcept C2776577112 @default.
• W2785220350 hasConcept C2776694085 @default.
• W2785220350 hasConcept C2778684742 @default.
• W2785220350 hasConcept C2779742858 @default.
• W2785220350 hasConcept C2780248432 @default.

• next